Speaker illustration

Doctor Jane Cochrane Caldwell

Hull and East Yorkshire Hospitals NHS Trust, Hull (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Heart Rythm Association

Having completed training in general cardiology in Glasgow, Jane obtained a PhD in cardiac cellular electrophysiology looking at the progression of ventricular fibrillation in ischemia, an area she has published widely in. Following this, she became a clinical lecturer at the University of Manchester and trained in clinical electrophysiology and device implantation at the Manchester Heart Centre. During this time, she researched and published on many aspects of atrial fibrillation and inherited arrhythmia. To further her clinical experience she undertook a clinical electrophysiology fellowship at Queen’s University, Kingston, Ontario. She now works as consultant electrophysiologist in Hull University Teaching Hospitals. In recognition of her on-going research activities, she is an Honorary Senior Lecturer in Cardiology at Hull York Medical School. She has established collaborations with the Engineering department to advance the knowledge of signal processing of cardiac rhythms.

Comparative cost-effectiveness of atrial fibrillation ablation versus pharmacological therapy.


Topic: Policy initiative

Session: Is it worth the money? Cost-effectiveness in electrophysiology


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb